Molecular target drives immunogenicity in cancer immunotherapy (IMAGE)

National University of Singapore

Molecular target drives immunogenicity in cancer immunotherapy

Caption

Figure (A) Mechanistic view of PlatinER induced ICD through PTP1B targeting. (B) Data illustrating ability of PlatinER and Pt-NHC to establish immunity against colorectal cancer in research models. (C) Schematic diagram illustrating target profiling processes, including photoaffinity labeling, click reaction, enrichment, tandem mass tags (TMT) quantitative proteomic analysis and target prioritisation.

Credit

National University of Singapore

Usage Restrictions

NA

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.